SCHEMBL8336673

SCHEMBL8336673

CNC(=S)N(C(=O)C(C)c1ccc(OC)c(N=S(=O)=O)c1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 5/20 0.35
▸ PKM P14618 1/20 0.35
▸ P2RX5 Q93086 1/20 0.34
▸ P2RX4 Q99571 1/20 0.34
▸ P2RX7 Q99572 1/20 0.34
▸ P2RX2 Q9UBL9 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ KMT2A Q03164 5/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ POLB P06746 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ FAAH O00519 3/20 0.32
▸ TOP2A P11388 2/20 0.32
▸ EPHX2 P34913 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ GPR55 Q9Y2T6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8336152 0.92 CNR2 (0.37) CNR2PKMP2RX5P2RX4P2RX7
SCHEMBL8336013 0.88 P2RX7 (0.31) P2RX4P2RX7
SCHEMBL8333655 0.82 — —
SCHEMBL8341312 0.81 POLB (0.38) CNR2PKMP2RX5P2RX4P2RX7
SCHEMBL8335857 0.81 GAA (0.31) LMNAKMT2ASMN1; SMN2GAA
SCHEMBL8334835 0.81 GAA (0.31) KMT2AGAA
SCHEMBL8864424 0.80 CNR2 (0.35) CNR2PKMP2RX5P2RX4P2RX7
SCHEMBL8334767 0.78 ALDH1A1 (0.33) LMNAKMT2ASMN1; SMN2GAA
SCHEMBL8339599 0.78 TSHR (0.36) KMT2AMEN1POLBGAA
SCHEMBL8333752 0.78 HIF1A (0.34) LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback